Elizabeth L. Hougen serves as the Executive Vice President, Finance and Chief Financial Officer at Ionis Pharmaceuticals Inc., a leading biotechnology company focused on developing RNA-targeted therapeutics. In her role, Hougen is responsible for overseeing the company's financial strategies, which include budgeting, forecasting, and financial reporting. Her leadership has been instrumental in ensuring Ionis maintains a strong financial position, enabling the company to continue its innovative work in the development of groundbreaking treatments for a range of diseases. Hougen brings a wealth of experience to Ionis, having spent over two decades in the biotechnology and pharmaceutical industries. Prior to joining Ionis, she held various senior financial positions at other notable companies, where she honed her skills in financial management and strategic planning. Her expertise in navigating the complex financial landscapes of the biotech sector has been a key factor in her success at Ionis. Under her guidance, the company has been able to secure funding for its research and development initiatives, ensuring the continued advancement of its therapeutic pipeline. In addition to her professional achievements, Hougen is known for her commitment to fostering a culture of transparency and accountability within Ionis. She plays a critical role in communicating financial performance to stakeholders, including investors and board members, ensuring they are well-informed about the company's progress and future plans. Her strategic vision and dedication to excellence have made her an invaluable asset to Ionis Pharmaceuticals, contributing significantly to the company's ongoing success and growth in the competitive biotechnology industry.